662101

Cooper Institute for Reproductive Hormonal Disorders, P.C. — FEI 3003914874

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 6, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mount Laurel, NJ (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1223121 CFR 1271.50(b)(1)Donor screening standards